Objective: To assess the effect of a new progestin progestogen only pill (desogestrel) versus an oral contraceptive in the treatment of recurrent endometriosis. Study design: A randomized prospective clinical study. A group of women with endometriosis (n = 40) who showed recurrent dysmenorrhea and/or pelvic pain after conservative surgery, and did not desire a pregnancy. Continuous treatment for 6 months with desogestrel (75 mu g/d) (n = 20) versus a combined oral contraceptive (ethinyl estradiol 20 mu g plus desogestrel 150 mu g) (n = 20) was performed. Results: A significant improvement of both pelvic pain and dysmenorrhea was observed following each type of treatment (P < 0.001). The use of desogestrel progestogen only pill was associated with a breakthrough bleeding in 20% patients, while a significant body weight increase was observed in 15% after oral contraceptive. Conclusions: Both desogestrel and an oral estro-progestinic were effective, safe and low cost therapy of pain symptoms after endoscopic surgery for endometriosis, the former showing an impact on breakthrough bleeding, the later an incidence on body weight increase

Razzi, S., Luisi, S., Ferretti, C., Calonaci, F., Gabbanini, M., Mazzini, M., et al. (2007). Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 135(2), 188-190 [10.1016/j.ejogrb.2006.08.002].

Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis

LUISI, S.;GABBANINI, M.;
2007-01-01

Abstract

Objective: To assess the effect of a new progestin progestogen only pill (desogestrel) versus an oral contraceptive in the treatment of recurrent endometriosis. Study design: A randomized prospective clinical study. A group of women with endometriosis (n = 40) who showed recurrent dysmenorrhea and/or pelvic pain after conservative surgery, and did not desire a pregnancy. Continuous treatment for 6 months with desogestrel (75 mu g/d) (n = 20) versus a combined oral contraceptive (ethinyl estradiol 20 mu g plus desogestrel 150 mu g) (n = 20) was performed. Results: A significant improvement of both pelvic pain and dysmenorrhea was observed following each type of treatment (P < 0.001). The use of desogestrel progestogen only pill was associated with a breakthrough bleeding in 20% patients, while a significant body weight increase was observed in 15% after oral contraceptive. Conclusions: Both desogestrel and an oral estro-progestinic were effective, safe and low cost therapy of pain symptoms after endoscopic surgery for endometriosis, the former showing an impact on breakthrough bleeding, the later an incidence on body weight increase
2007
Razzi, S., Luisi, S., Ferretti, C., Calonaci, F., Gabbanini, M., Mazzini, M., et al. (2007). Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 135(2), 188-190 [10.1016/j.ejogrb.2006.08.002].
File in questo prodotto:
File Dimensione Formato  
use of.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 188.22 kB
Formato Adobe PDF
188.22 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/31778
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo